Agenus to Participate in Jefferies Healthcare Conference
May 25 2023 - 7:30AM
Business Wire
Agenus (NASDAQ: AGEN), an immuno-oncology company with an
extensive pipeline of clinical and preclinical-stage cancer
treatments, today announced that Dr. Garo Armen, Chairman and CEO,
will participate in a fireside chat and investor one-on-ones at the
upcoming Jefferies Healthcare Conference on June 8th at the Marriot
Marquis in New York. The fireside chat will take place at 1pm ET on
June 8th.
A live webcast of the fireside can be accessed on the company’s
website at https://investor.agenusbio.com/events-and-presentations.
A replay will be posted following the event.
About Agenus Agenus is a
clinical-stage immuno-oncology company focused on the discovery and
development of therapies that engage the body's immune system to
fight cancer and infections. The Company's vision is to expand the
patient populations benefiting from cancer immunotherapy by
pursuing combination approaches that leverage a broad repertoire of
antibody therapeutics, adoptive cell therapies (through its
subsidiary MiNK Therapeutics), and adjuvants (through its
subsidiary SaponiQx). The Company is equipped with a suite of
antibody discovery platforms and a state-of-the-art GMP
manufacturing facility with the capacity to support clinical
programs. Agenus is headquartered in Lexington, MA. For more
information, please visit www.agenusbio.com and our Twitter handle
@agenus_bio. Information that may be important to investors will be
routinely posted on our website and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230525005199/en/
Agenus Inc. Zack Armen Head of Investor Relations 917-362-1370
zack.armen@agenusbio.com
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024